Business
Corporate Update
Corporate Update.
About this update from Fortis Frontier Plc
[{"type":"text","content":"\n \nRNS Number : 7958O Concepta PLC 23 August 2017 \n\nDissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR)\n \n23 August 2017\n \nConcepta plc\n(\"Concepta\" or the \"Company\")\nCORPORATE UPDATE\n \nConcepta makes first shipment of myLotus fertility product to China\n \nFounding member of Company appointed Head of China Operations\n \nConcepta plc (AIM: CPT) the pioneering UK healthcare company and developer of a proprietary platform and suite of products targeted at the personalised mobile health market with a primary focus on women's fertility and specifically unexplained infertility, is pleased to provide a positive update regarding its marketing and sales drive into China of its myLotus fertility product.\n \nFollowing the receipt of its first sales order, totalling £225,000, for its myLotus fertility product from its partner in China, HuanZhong Biotech Co.Ltd (see announcement 13 June 2017), the Company has made its first shipment of products to China. As part of this first shipment, the Company scaled up production of its test strips at its UK manufacturing site in Sharnbrook, Bedfordshire, allowing it to shorten its lead-time for shipment by two weeks. The Company expects to make further regular shipments to fulfil this order in the coming weeks.\nThe Company is also pleased to announce that it has appointed Zhang Zhi Gang, as Head of China Operations. Zhang was one of the founders of Concepta Diagnostics Limited and led the way in developing key contacts in China for manufacturing and distribution. Zhang has extensive knowledge of the Chinese healthcare market. Her previous position was as General Manager at Alere China Co. Ltd (\"Alere\"). During her time at Alere she helped launch 8 new products and managed 5 product lines. Previously to this Zhang was at Unipath UK where she helped develop the patented algorithms currently used by Clearblue's range of fertility and pregnancy test products.\n \nZhang is currently managing a hospital evaluation process for Concepta to support the use of myLotus products for early pregnancy monitoring. This application is of particular importance in China, where the use of myLotus is seen as an opportunity to reduce the overwhelming number of hospital appointments ...